Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd    600332   CNE000001733

GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD

(600332)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/18/2019 02/19/2019 02/20/2019 02/21/2019 02/22/2019 Date
36.21(c) 36.5(c) 36.27(c) 35.57(c) 35.31 Last
15 246 708 15 861 832 8 080 930 14 041 150 11 934 590 Volume
+3.96% +0.80% -0.63% -1.93% -0.73% Change
More quotes
Financials (CNY)
Sales 2018 37 594 M
EBIT 2018 3 066 M
Net income 2018 3 931 M
Finance 2018 8 232 M
Yield 2018 1,52%
Sales 2019 52 847 M
EBIT 2019 3 412 M
Net income 2019 3 357 M
Finance 2019 6 974 M
Yield 2019 1,47%
P/E ratio 2018 16,36
P/E ratio 2019 18,27
EV / Sales2018 2,28x
EV / Sales2019 1,65x
Capitalization 93 980 M
More Financials
Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is engaged in the pharmaceutical and healthcare industry. The Company's segments are Great Southern TCM, Great Commerce, Great Health and Great Medical Care. The Company's Great South TCM includes research, development, manufacturing and... 
Sector
Pharmaceuticals
Calendar
03/15Earnings Release
More about the company
Surperformance© ratings of Guangzhou Baiyunshan Phrmc
Trading Rating : Investor Rating :
More Ratings
Latest news on GUANGZHOU BAIYUNSHAN PHRMC
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan interim net up 126% to RMB2.6b; n..
AQ
2018GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Ex-dividend day for final dividend
FA
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan 1Q net profit up 87% to Rmb905m
AQ
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS : Baiyunshan year net up 36.7% to Rmb2.06bn; d..
AQ
2018GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : annual earnings release
2017GUANGZHOU BAIYUNSHAN PHARMACEUTICAL : Annual Report
CO
2017GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for final dividend
FA
2016GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for extraordinary dividen..
FA
2016GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : annual earnings release
2015GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO : Ex-dividend day for final dividend
FA
More news
Analyst Recommendations on GUANGZHOU BAIYUNSHAN PHRMC
More recommendations
Sector news : Pharmaceuticals - NEC
02/21BAYER : DowDuPont wins final OK for global launch of new GMO soybeans
RE
02/21GLOBAL MARKETS LIVE : J&J, UBS, YouTube, Standard Chartered…
02/21MERCK AND : to Buy Immune Design for $5.85 A Share
DJ
02/21JOHNSON & JOHNSON : J&J Gets Subpoenas Related To Talc
DJ
02/21BRISTOL MYERS SQUIBB : Starboard Nominates Bristol Board Members
DJ
More sector news : Pharmaceuticals - NEC
Chart GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD
Duration : Period :
Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUANGZHOU BAIYUNSHAN PHRMC
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Average target price 39,7  CNY
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Hong Li General Manager & Director
Chu Yuan Li Chairman
Jia Xiong Xian Chairman-Supervisory Board
Hin Wing Wong Independent Non-Executive Director
Chang Hai Wu Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
GUANGZHOU BAIYUNSHAN PHRMCL HLDGS CO LTD-0.53%13 973
JOHNSON & JOHNSON5.66%365 688
PFIZER-3.32%244 760
ROCHE HOLDING LTD.13.68%237 660
NOVARTIS7.90%231 060
MERCK AND COMPANY3.95%206 548